A Randomized, Parallel, Double-blind, Placebo-controlled Study of Vitamin D as Prophylactic Treatment for Migraine
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The trial is primarily designed to investigate whether treatment with vitamin D may influence
migraine in a placebo-controlled, blinded study. The hypothesis is that vitamin D may serve
as a prophylactic treatment of migraine. The hypothesis is tested by examining the changes in
the pain and symptom patterns associated with migraine by treatment with Vitamin D, by means
of quantitative sensory testing, diaries and blood samples for measurement of vitamin D.
Other pain biomarkers are also measured to evaluate whether the levels of these biomarkers in
the blood is changed by the treatment with vitamin D. The hypothesis here is that levels of
those biomarkers will change following the treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Aalborg University
Collaborators:
Aalborg Universitetshospital Aalborg University Hospital CCBR Aalborg A/S, Aalborg, Denmark
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins